Lexaria Bioscience Corp. (LEXX)

NASDAQ: LEXX · Real-Time Price · USD

0.8248

-0.0233 (-2.75%)

At close: Oct 16, 2025, 4:00 PM EDT

0.8073

-0.0175 (-2.12%)

After-hours: Oct 16, 2025, 4:02 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	2015 - 2019
Intellectual Property Licensing	457.99K	Log In	Log In	Log In	Log In	Upgrade
Intellectual Property Licensing Growth	211.98%	Log In	Log In	Log In	Log In	Upgrade
Business-to-business Product	5.39K	Log In	Log In	Log In	Log In	Upgrade
Business-to-business Product Growth	-87.80%	Log In	Log In	Log In	Log In	Upgrade
Research & Development	900.00	Log In	Log In	Log In	Log In	Upgrade
Research & Development Growth	-97.45%	Log In	Log In	Log In	Log In	Upgrade
Corporate	-	Log In	Log In	Log In	Log In	Upgrade
Corporate Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	2015 - 2019
United States and Canada	464.28K	Log In	Log In	Log In	Log In	Upgrade
United States and Canada Growth	105.24%	Log In	Log In	Log In	Log In	Upgrade